Breast Cancer specifically Stage IIb and Stage IIIa Breast neoplasms Neoadjuvant therapy Biopsy, Fine-Needle Sensitivity and specificity Developing countries
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Adults aged 18 to 60 years 2. both female and male (majority female, 93.9%) 3.Context Post-neoadjuvant chemotherapy (NAC) axillary lymph node staging
Exclusion criteria
Exclusion criteria: 1.Recurrent/metastatic disease 2.Inflammatory breast carcinoma 3.Recurrent/metastatic disease 4.Inflammatory breast carcinoma 5.Cardiomyopathy 6.Progressive disease during NAC
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity, Specificity Positive Predictive Value, Negative Predictive Value post-neoadjuvant chemotherapy (post-NAC), immediately prior to surgery metrics collectively measure diagnostic accuracy, clinical utility, and the feasibility of using USG-FNAC as a triage tool in LMIC settings.,Sensitivity, specificity, PPV NPV All assessments were conducted post neoadjuvant chemotherapy (post NAC):USG FNAC performed on axillary lymph nodes ALND performed immediately after FNAC (reference standard) Sensitivity, spicificity, PPV, NOV | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity,Specificity,PPV NPV NA Sensitivity,specificity Pov NOV | — |
Countries
Pakistan
Contacts
King Edward Medical University (KEMU), Lahore, Pakistan the teaching and academic institution affiliated with Mayo Hospital